Market Overview

Piper Jaffray Initiates Coverage on Life Technologies at Neutral, Announces PT of $42

Share:
Related LIFE
aTyr Pharma Initiates Phase 1b/2 Clinical Trial for Patients with Limb Girdle Muscular Dystrophy 2B
aTyr Pharma Announces Change in Leadership

Latest Ratings for LIFE

DateFirmActionFromTo
Dec 2015CitigroupInitiates Coverage onNeutral
Jun 2015JP MorganInitiates Coverage onOverweight
Aug 2013BairdDowngradesOutperformNeutral

View More Analyst Ratings for LIFE
View the Latest Analyst Ratings

Posted-In: Piper JaffrayPrice Target Initiation Analyst Ratings

 

Related Articles (LIFE)

View Comments and Join the Discussion!

Get Benzinga's Newsletters